These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33093188)

  • 1. Ad Watch: 'Unstoppable' VUSE Alto TV Spot Closely Mirrors 'Nicotine Addiction Checks' on TikTok.
    Marynak KL; Moran M
    Tob Control; 2021 Nov; 30(e1):e60-e61. PubMed ID: 33093188
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat not burn tobacco promotion on instagram.
    Kreitzberg DS; Murthy D; Loukas A; Pasch KE
    Addict Behav; 2019 Apr; 91():112-118. PubMed ID: 30241774
    [No Abstract]   [Full Text] [Related]  

  • 3. PMI New Zealand conflates IQOS heated tobacco products with electronic nicotine delivery systems.
    Robertson L; Hoek J; Silver K
    Tob Control; 2023 Jul; 32(4):534-536. PubMed ID: 34799435
    [No Abstract]   [Full Text] [Related]  

  • 4. 'Help Save The Planet One Bidi Stick At A Time!': greenwashing disposable vapes.
    Heley K; Czaplicki L; Kennedy RD; Moran M
    Tob Control; 2022 Sep; 31(5):675-678. PubMed ID: 33782198
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of FDA's Vuse market authorisation: limitations and opportunities.
    Meshnick AB; Faricy LE; Lushniak BD
    Tob Control; 2024 Mar; 33(e1):e116-e121. PubMed ID: 36764685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. #PuffBar: how do top videos on TikTok portray Puff Bars?
    Tan ASL; Weinreich E
    Tob Control; 2021 Nov; 30(6):712-713. PubMed ID: 32934090
    [No Abstract]   [Full Text] [Related]  

  • 7. Electronic cigarette advertising at the point-of-sale: a gap in tobacco control research.
    Ganz O; Cantrell J; Moon-Howard J; Aidala A; Kirchner TR; Vallone D
    Tob Control; 2015 Mar; 24(e1):e110-2. PubMed ID: 24619455
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum.
    Stiles MF; Campbell LR; Jin T; Graff DW; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2018 Jul; 235(7):2077-2086. PubMed ID: 29725702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Van Hoof D; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108441. PubMed ID: 33250386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social media use by leading US e-cigarette, cigarette, smokeless tobacco, cigar and hookah brands.
    O'Brien EK; Hoffman L; Navarro MA; Ganz O
    Tob Control; 2020 Dec; 29(e1):e87-e97. PubMed ID: 32217772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco control without a maximum nicotine level in products is a smokescreen.
    Braillon A
    BMJ; 2022 Aug; 378():o1942. PubMed ID: 35940613
    [No Abstract]   [Full Text] [Related]  

  • 12. Undermining Australian controls on electronic nicotine delivery systems: illicit imports and illegal sales.
    Dessaix A; Jardine E; Freeman B; Kameron C
    Tob Control; 2022 Nov; 31(6):689-690. PubMed ID: 36265869
    [No Abstract]   [Full Text] [Related]  

  • 13. Making the Case for Nicotine Addiction: Select Reminiscences - A Commentary on Kozlowski et al. (2020).
    Jaffe JH
    J Stud Alcohol Drugs; 2020 Nov; 81(6):738-739. PubMed ID: 33308402
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaping industry-funded academic scholarships.
    Baler G; Paci K; Kowitt SD; Goldstein AO
    Tob Control; 2020 Dec; 29(e1):e181-e182. PubMed ID: 31879374
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.
    Stiles MF; Campbell LR; Graff DW; Jones BA; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2017 Sep; 234(17):2643-2655. PubMed ID: 28634710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry sponsored harm reduction conference courts Indigenous peoples in Canada.
    Thompson S; Smith J; Lee K; Thompson S
    Tob Control; 2020 Dec; 29(e1):e130-e131. PubMed ID: 32474409
    [No Abstract]   [Full Text] [Related]  

  • 17. Industry tactics in anticipation of strengthened regulation: BIDI Vapor unveils non-characterising BIDI Stick flavours on digital media platforms.
    Kostygina G; Kreslake JM; Borowiecki M; Kierstead EC; Diaz MC; Emery SL; Schillo B
    Tob Control; 2023 Jan; 32(1):121-123. PubMed ID: 34078653
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploitation of the COVID-19 pandemic by e-cigarette marketers.
    Ramamurthi D; Chau C; Jackler RK
    Tob Control; 2021 Nov; 30(e1):e56-e59. PubMed ID: 32855354
    [No Abstract]   [Full Text] [Related]  

  • 19. Achievements, challenges, priorities and needs to address the current tobacco epidemic in Latin America.
    Sóñora G; Reynales-Shigematsu LM; Barnoya J; Llorente B; Szklo AS; Thrasher JF
    Tob Control; 2022 Mar; 31(2):138-141. PubMed ID: 35241577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Price-related promotions for tobacco products on Twitter.
    Jo CL; Kornfield R; Kim Y; Emery S; Ribisl KM
    Tob Control; 2016 Jul; 25(4):476-9. PubMed ID: 26130449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.